Search
Resources Library
Test, Evaluate, Monitor
Testing and Linkage to Care
When and in Whom to Initiate HCV Therapy
Cost, Reimbursement, and Cost-Effectiveness
Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy
Incomplete Adherence
HCV Resistance Primer
Treatment-Naive
Simplified: No Cirrhosis
Simplified: Compensated Cirrhosis
Decompensated Cirrhosis
Genotype 1
Genotype 2
Genotype 3
Genotype 4
Genotype 5 or 6
Treatment-Experienced Patients
SOF-Based and ELB/GRZ Treatment Failures
G/P Treatment Failures
Multiple DAA Treatment Failures
Decompensated Cirrhosis
Unique & Key Populations
HIV/HCV Coinfection
Decompensated Cirrhosis
Post Liver Transplant
Organs from HCV-Viremic Donors
Renal Impairment
Kidney Transplant
Acute Infection
HCV in Pregnancy
HCV in Children
PWID, MSM & Corrections
About
Announcements
Organizations
HCV Guidance Panel
Disclosures
Process
Citing and Permissions
Survey
Website Policies
Contact Us
Test, Evaluate, Monitor
Testing and Linkage to Care
When and in Whom to Initiate HCV Therapy
Cost, Reimbursement, and Cost-Effectiveness
Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy
Incomplete Adherence
HCV Resistance Primer
Treatment-Naive
Simplified: No Cirrhosis
Simplified: Compensated Cirrhosis
Decompensated Cirrhosis
Genotype 1
Genotype 2
Genotype 3
Genotype 4
Genotype 5 or 6
Treatment-Experienced Patients
SOF-Based and ELB/GRZ Treatment Failures
G/P Treatment Failures
Multiple DAA Treatment Failures
Decompensated Cirrhosis
Unique & Key Populations
HIV/HCV Coinfection
Decompensated Cirrhosis
Post Liver Transplant
Organs from HCV-Viremic Donors
Renal Impairment
Kidney Transplant
Acute Infection
HCV in Pregnancy
HCV in Children
PWID, MSM & Corrections
About
Announcements
Organizations
HCV Guidance Panel
Disclosures
Process
Citing and Permissions
Survey
Website Policies
Contact Us
Resource Library
First Post Example
March 27, 2025
Second Example Post
March 26, 2025
Third Post Example
March 25, 2025
